Back to search
Scientific Name: Cysteamine
Brand Name: Cystagon, Cystaran, Procysbi
Company Owner: Mylan pharmaceuticals inc
Mechanism Of Action Individuals born without the ability to metabolize cystine suffer from cystinosis, a rare genetic disorder characterized by the widespread accumulation of cystine crystals throughout the body and eye tissues. The cystine crystals may cause considerable damage, particularly in the renal tissues and corneal tissues. In some cases, renal failure can occur during childhood if the condition is left untreated. Other organs that may be affected by cystinosis include the CNS, thyroid, pancreas, muscle tissues, and gonads.
Description of the Drug: Cysteamine is a cystine depleting agent used to treat the effects of cystinosis.
Protein Data Bank:
Source: DrugBank Online – Retrieved 2023-01-23 from